PharmiWeb.com - Global Pharma News & Resources
02-Oct-2025

Ciloa

After securing €6.5M in funding, Ciloa, a French biotech pioneer specializing in the in‑vivo bio‑engineering of small extracellular vesicles for therapeutic and preventive use wished to raise its profile and earn broader market recognition, particularly for its applications in metabolic‑disease treatment.

Editor Details

Last Updated: 02-Oct-2025